+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Bioinformatics Market by Product Types, Applications, End-User - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083774
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Bioinformatics Market grew from USD 13.33 billion in 2024 to USD 15.00 billion in 2025. It is expected to continue growing at a CAGR of 12.97%, reaching USD 27.72 billion by 2030.

Setting the Stage for Bioinformatics Innovation

Bioinformatics has emerged as the backbone of modern life sciences, driving breakthroughs across healthcare, agriculture, and environmental research. As genomic sequencing costs plummet, organizations face both unprecedented opportunity and complexity: integrating vast datasets, deploying sophisticated analytical platforms, and navigating evolving regulatory landscapes. This introduction articulates the critical role that bioinformatics plays in accelerating discovery and optimizing decision-making processes, setting the stage for deeper analysis.

By examining the convergence of high-throughput sequencing, cloud computing, and artificial intelligence, we highlight how stakeholders-from academic researchers to pharmaceutical giants-leverage bioinformatics to decode genetic blueprints, identify novel therapeutic targets, and streamline breeding programs. This overview underscores the transformative potential of data-driven methodologies, framing the subsequent sections that explore disruptive market shifts, geopolitical influences, segmentation insights, and actionable recommendations for sustained competitive advantage.

Emerging Forces Redefining Bioinformatics Landscape

Recent years have witnessed transformative shifts that are redefining the bioinformatics landscape. Advances in machine learning algorithms now enable real-time pattern recognition in genomics datasets, while the rise of multi-omics integration is breaking down silos between genomics, proteomics, and metabolomics. These innovations empower researchers to construct holistic models of biological systems, accelerating drug discovery and precision medicine initiatives.

Simultaneously, democratization of sequencing technologies has broadened access beyond elite laboratories to small biotech startups and regional diagnostic centers. This diffusion of capabilities fuels a dynamic ecosystem where agile players partner with established institutions to co-develop tailored solutions. Regulatory bodies are also responding to these changes, crafting more nuanced frameworks for data sharing and intellectual property protection. Collectively, these forces are catalyzing a shift from isolated experiments to collaborative, high-throughput pipelines that yield actionable insights at unprecedented scale.

Assessing the 2025 US Tariff Ripple Effects

The implementation of new tariffs on bioinformatics hardware and reagents in the United States is poised to reverberate across global supply chains in 2025. Increased duties on imported sequencing instruments and critical consumables will elevate procurement costs for laboratory operators, particularly those reliant on advanced platforms for high-throughput data generation. As a result, budget allocations may shift, prioritizing cost-containment strategies and in-house service offerings.

These tariff-induced pressures will compel bioinformatics service providers to revisit pricing models and optimize resource utilization. Organizations may intensify partnerships with domestic manufacturing firms to mitigate exposure to import levies. At the same time, end-users may delay capital investments or explore secondhand equipment markets, altering demand patterns for new platform deployment. Understanding the cumulative impact of these policy measures is essential for stakeholders aiming to navigate elevated operational costs and sustain momentum in research and development activities.

Decoding Market Segments for Targeted Growth

A granular segmentation analysis reveals the diverse product, application, and end-user landscapes that define the bioinformatics market. In terms of product types, the domain encompasses comprehensive platforms for sequence alignment, analysis, manipulation, as well as structural and functional interpretation, alongside specialized services for data analysis, database management, and sequencing operations, and knowledge management tools that centralize data repositories. Each category addresses distinct pain points: alignment platforms accelerate comparative studies, analysis suites extract actionable patterns from raw reads, manipulation environments facilitate tailored workflows, and functional analysis systems decode molecular interactions.

Across applications, solutions cater to agricultural biotechnology initiatives focused on genetically modified organism development and plant breeding optimization, clinical diagnostics that demand rapid and precise pathogen detection, and drug discovery pipelines engaged in targeted screening and candidate validation. Genomics research journeys from comparative to functional studies, while proteomics and metabolomics platforms uncover protein expression profiles and metabolic fingerprints, driving insights from bench to bedside.

End-users range from academic research laboratories and universities that fuel fundamental discoveries to agricultural and environmental sectors implementing resilience strategies for crop and ecosystem health, healthcare providers including diagnostic centers and hospital networks, and pharmaceutical and biotechnology companies pushing therapeutic innovation. Recognizing the interdependencies among these segments enables stakeholders to align product development, marketing, and partnership strategies with evolving market requirements.

Unearthing Regional Dynamics Shaping Market Expansion

Regional dynamics exert a profound influence on the evolution of bioinformatics capabilities and investment priorities. In the Americas, a strong concentration of leading genomics institutions, venture-backed startups, and federal funding bodies fosters an environment of rapid innovation, with North American hubs driving cloud-based analytics adoption and Latin American entities expanding capacity for agricultural genomics.

The Europe, Middle East & Africa region exhibits heterogeneous maturity levels, where Western European nations leverage robust regulatory frameworks and public-private collaborations to advance personalized medicine, while emerging markets in the Middle East invest heavily in precision agriculture. In Africa, the imperative to tackle endemic diseases has spurred capacity-building initiatives and regional sequencing consortia, enhancing local research sovereignty.

In Asia-Pacific, governments are scaling flagship programs in genomics and digital health, with mega-sequencing centers in China and Japan catalyzing large-scale population studies and molecular diagnostics. Investment in homegrown bioinformatics platforms and services reflects a strategic drive for technological self-reliance. This regional mosaic shapes vendor strategies, partnership models, and resource allocation, underscoring the need for tailored engagement approaches.

Profiling Industry Leaders Driving Bioinformatics Progress

Industry leaders are distinguished by their comprehensive portfolios, strategic alliances, and investments in next-generation technologies. The foremost platform providers have consistently expanded their offerings to integrate artificial intelligence modules, cloud-native architectures, and intuitive visualization capabilities that accelerate interpretive workflows. Service-focused organizations bolster their propositions through end-to-end sequencing pipelines and dedicated data stewardship, ensuring compliance with evolving privacy regulations.

In the realm of knowledge management, key players differentiate themselves by delivering collaborative environments that unify disparate datasets across research teams, enabling reproducible analyses and streamlined regulatory submissions. Partnerships between technology firms and academic consortia have yielded co-developed solutions that address niche applications, from epigenomic profiling to single-cell transcriptomics. Observing these competitive dynamics provides benchmarks for investment, innovation roadmaps, and potential merger and acquisition targets.

Strategic Imperatives to Seize Competitive Advantage

To sustain leadership and capitalize on emerging opportunities, organizations must adopt strategic imperatives focused on technology, partnerships, and talent development. Prioritizing modular, interoperable platforms will enable rapid integration of cutting-edge algorithms and third-party applications, fostering an ecosystem of innovation. Establishing collaborative frameworks with academic institutions and regulatory bodies accelerates validation cycles and enhances market readiness for novel diagnostics and therapeutics.

Investment in workforce upskilling is equally critical; cultivating interdisciplinary teams proficient in computational biology, data science, and regulatory affairs ensures agility in responding to complex project requirements. Additionally, implementing robust data governance policies safeguards intellectual property and enhances stakeholder confidence. These recommendations serve as a blueprint for executives aiming to reinforce their competitive positioning and drive sustainable growth in a rapidly evolving landscape.

Rigorous Research Framework Ensuring Insight Credibility

The research underpinning this analysis employs a multi-tiered methodology to ensure rigor and relevance. Primary data were gathered through in-depth interviews with domain experts, including bioinformatics scientists, lab managers, and policy advisors, complemented by surveys across end-user segments. Secondary data collection drew upon peer-reviewed literature, patent databases, regulatory filings, and corporate disclosures to triangulate market trends and technology trajectories.

Quantitative assessment involved rigorous validation of market structure, segmentation parameters, and competitive benchmarking, while qualitative insights illuminated strategic priorities and innovation drivers. Analytical frameworks such as SWOT, Porter’s Five Forces, and cross-regional comparative matrices were applied to synthesize findings. This comprehensive approach guarantees that conclusions rest on verifiable evidence and reflect the most current developments in bioinformatics.

Synthesizing Insights for Informed Decision Making

This executive summary distills critical insights to guide informed decision-making in bioinformatics. By mapping transformative technological shifts, assessing geopolitical impacts, and articulating segmentation and regional nuances, stakeholders gain a holistic perspective on both challenges and growth vectors. Profiling market leaders and outlining strategic imperatives further equips executives with pragmatic pathways to innovation and market leadership.

The interplay of data-driven discovery, agile partnerships, and targeted investments emerges as the linchpin for success. As organizations navigate the complexities of tariffs, regulatory landscapes, and evolving end-user needs, the integrated analysis presented here serves as a strategic compass. Embracing these insights will empower stakeholders to optimize resource allocation, refine go-to-market strategies, and ultimately deliver impactful solutions that advance scientific progress and commercial success.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Types
    • Bioinformatics Platforms
      • Sequence Alignment Platforms
      • Sequence Analysis Platforms
      • Sequence Manipulation Platforms
      • Structural & Functional Analysis Platforms
    • Bioinformatics Services
      • Data Analysis
      • Database Management
      • Sequencing
    • Knowledge Management Tools
  • Applications
    • Agricultural Biotechnology
      • GMOs Development
      • Plant Breeding Tools
    • Clinical Diagnostics
    • Drug Discovery & Development
      • Drug Screening
      • Target Identification
    • Genomics
      • Comparative Genomics
      • Functional Genomics
    • Proteomics & Metabolomics
  • End-User
    • Academic & Research Institutes
      • Research Labs
      • Universities
    • Agricultural & Environmental Sectors
    • Healthcare Providers
      • Diagnostic Centers
      • Hospitals
    • Pharmaceutical & Biotechnology Companies
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • BioDiscovery Group
  • biomodal Limited
  • Dassault Systèmes S.E.
  • DNASTAR, Inc.
  • Eurofins Genomics LLC
  • F. Hoffmann-La Roche Ltd
  • Genevia Technologies Oy
  • Genomics Ltd.
  • HaploX
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc.
  • Labcorp Genetics Inc.
  • Labvantage - Biomax GmbH
  • Novo Nordisk A/S
  • Oxford Nanopore Technologies plc.
  • Pacific Biosciences of California, Inc.
  • Partek Incorporated
  • PerkinElmer, Inc.
  • Qiagen N.V.
  • RIKEN GENESIS CO.,LTD.
  • SOPHiA GENETICS SA
  • Telesis Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Veracyte, Inc.
  • Waters Corporation

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bioinformatics Market, by Product Types
8.1. Introduction
8.2. Bioinformatics Platforms
8.2.1. Sequence Alignment Platforms
8.2.2. Sequence Analysis Platforms
8.2.3. Sequence Manipulation Platforms
8.2.4. Structural & Functional Analysis Platforms
8.3. Bioinformatics Services
8.3.1. Data Analysis
8.3.2. Database Management
8.3.3. Sequencing
8.4. Knowledge Management Tools
9. Bioinformatics Market, by Applications
9.1. Introduction
9.2. Agricultural Biotechnology
9.2.1. GMOs Development
9.2.2. Plant Breeding Tools
9.3. Clinical Diagnostics
9.4. Drug Discovery & Development
9.4.1. Drug Screening
9.4.2. Target Identification
9.5. Genomics
9.5.1. Comparative Genomics
9.5.2. Functional Genomics
9.6. Proteomics & Metabolomics
10. Bioinformatics Market, by End-User
10.1. Introduction
10.2. Academic & Research Institutes
10.2.1. Research Labs
10.2.2. Universities
10.3. Agricultural & Environmental Sectors
10.4. Healthcare Providers
10.4.1. Diagnostic Centers
10.4.2. Hospitals
10.5. Pharmaceutical & Biotechnology Companies
11. Americas Bioinformatics Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Bioinformatics Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Bioinformatics Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. 10x Genomics, Inc.
14.3.2. Agilent Technologies, Inc.
14.3.3. BGI Group
14.3.4. Bio-Rad Laboratories, Inc.
14.3.5. BioDiscovery Group
14.3.6. biomodal Limited
14.3.7. Dassault Systèmes S.E.
14.3.8. DNASTAR, Inc.
14.3.9. Eurofins Genomics LLC
14.3.10. F. Hoffmann-La Roche Ltd
14.3.11. Genevia Technologies Oy
14.3.12. Genomics Ltd.
14.3.13. HaploX
14.3.14. Illumina, Inc.
14.3.15. Integrated DNA Technologies, Inc.
14.3.16. Labcorp Genetics Inc.
14.3.17. Labvantage - Biomax GmbH
14.3.18. Novo Nordisk A/S
14.3.19. Oxford Nanopore Technologies plc.
14.3.20. Pacific Biosciences of California, Inc.
14.3.21. Partek Incorporated
14.3.22. PerkinElmer, Inc.
14.3.23. Qiagen N.V.
14.3.24. RIKEN GENESIS CO.,LTD.
14.3.25. SOPHiA GENETICS SA
14.3.26. Telesis Bio Inc.
14.3.27. Thermo Fisher Scientific Inc.
14.3.28. Veracyte, Inc.
14.3.29. Waters Corporation
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. BIOINFORMATICS MARKET MULTI-CURRENCY
FIGURE 2. BIOINFORMATICS MARKET MULTI-LANGUAGE
FIGURE 3. BIOINFORMATICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOINFORMATICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOINFORMATICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOINFORMATICS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOINFORMATICS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BIOINFORMATICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BIOINFORMATICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BIOINFORMATICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BIOINFORMATICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOINFORMATICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOINFORMATICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOINFORMATICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOINFORMATICS MARKET SIZE, BY SEQUENCE ALIGNMENT PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOINFORMATICS MARKET SIZE, BY SEQUENCE ANALYSIS PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOINFORMATICS MARKET SIZE, BY SEQUENCE MANIPULATION PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOINFORMATICS MARKET SIZE, BY STRUCTURAL & FUNCTIONAL ANALYSIS PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOINFORMATICS MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOINFORMATICS MARKET SIZE, BY DATABASE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOINFORMATICS MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOINFORMATICS MARKET SIZE, BY KNOWLEDGE MANAGEMENT TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOINFORMATICS MARKET SIZE, BY GMOS DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOINFORMATICS MARKET SIZE, BY PLANT BREEDING TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOINFORMATICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOINFORMATICS MARKET SIZE, BY DRUG SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOINFORMATICS MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOINFORMATICS MARKET SIZE, BY GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOINFORMATICS MARKET SIZE, BY COMPARATIVE GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOINFORMATICS MARKET SIZE, BY FUNCTIONAL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOINFORMATICS MARKET SIZE, BY PROTEOMICS & METABOLOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOINFORMATICS MARKET SIZE, BY RESEARCH LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOINFORMATICS MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL & ENVIRONMENTAL SECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOINFORMATICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOINFORMATICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOINFORMATICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES BIOINFORMATICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 67. CANADA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 68. CANADA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 69. CANADA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 70. CANADA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 71. CANADA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 72. CANADA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 73. CANADA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 74. CANADA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. CANADA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 76. CANADA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 77. MEXICO BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 78. MEXICO BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 79. MEXICO BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 80. MEXICO BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 81. MEXICO BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. MEXICO BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 83. MEXICO BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 84. MEXICO BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. MEXICO BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 86. MEXICO BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. UNITED KINGDOM BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 128. GERMANY BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 129. GERMANY BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 130. GERMANY BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 131. GERMANY BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 132. GERMANY BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. GERMANY BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 134. GERMANY BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 135. GERMANY BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. GERMANY BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 137. GERMANY BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 138. FRANCE BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 139. FRANCE BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 140. FRANCE BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 141. FRANCE BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 142. FRANCE BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. FRANCE BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 144. FRANCE BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 145. FRANCE BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. FRANCE BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 147. FRANCE BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 158. ITALY BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 159. ITALY BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 160. ITALY BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 161. ITALY BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 162. ITALY BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 163. ITALY BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 164. ITALY BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 165. ITALY BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. ITALY BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 167. ITALY BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 168. SPAIN BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 169. SPAIN BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 170. SPAIN BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 171. SPAIN BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 172. SPAIN BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. SPAIN BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 174. SPAIN BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 175. SPAIN BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. SPAIN BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 177. SPAIN BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 188. SAUDI ARABIA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 208. DENMARK BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 209. DENMARK BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 210. DENMARK BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 211. DENMARK BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 212. DENMARK BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 213. DENMARK BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 214. DENMARK BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 215. DENMARK BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 216. DENMARK BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 217. DENMARK BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 218. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 219. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 220. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 221. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 222. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 223. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 224. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 225. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 226. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 227. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 228. QATAR BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 229. QATAR BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 230. QATAR BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 231. QATAR BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 232. QATAR BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 233. QATAR BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 234. QATAR BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 235. QATAR BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 236. QATAR BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 237. QATAR BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 238. FINLAND BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 239. FINLAND BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 240. FINLAND BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 241. FINLAND BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 242. FINLAND BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 243. FINLAND BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 244. FINLAND BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 245. FINLAND BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 246. FINLAND BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 247. FINLAND BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 258. NIGERIA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 259. NIGERIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 260. NIGERIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 261. NIGERIA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 262. NIGERIA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 263. NIGERIA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 264. NIGERIA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 265. NIGERIA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 266. NIGERIA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 267. NIGERIA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 268. EGYPT BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 269. EGYPT BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 270. EGYPT BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 271. EGYPT BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 272. EGYPT BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 273. EGYPT BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 274. EGYPT BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 275. EGYPT BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 276. EGYPT BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 277. EGYPT BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 278. TURKEY BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 279. TURKEY BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 280. TURKEY BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 281. TURKEY BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 282. TURKEY BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 283. TURKEY BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 284. TURKEY BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 285. TURKEY BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 286. TURKEY BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 287. TURKEY BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 288. ISRAEL BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 289. ISRAEL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 290. ISRAEL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 291. ISRAEL BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 292. ISRAEL BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 293. ISRAEL BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 294. ISRAEL BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 295. ISRAEL BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 296. ISRAEL BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 297. ISRAEL BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 298. NORWAY BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 299. NORWAY BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 300. NORWAY BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 301. NORWAY BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 302. NORWAY BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 303. NORWAY BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 304. NORWAY BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 305. NORWAY BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 306. NORWAY BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 307. NORWAY BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 308. POLAND BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 309. POLAND BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 310. POLAND BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 311. POLAND BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 312. POLAND BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 313. POLAND BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 314. POLAND BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 315. POLAND BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 316. POLAND BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 317. POLAND BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 318. SWITZERLAND BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 319. SWITZERLAND BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 320. SWITZERLAND BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 321. SWITZERLAND BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 322. SWITZERLAND BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 323. SWITZERLAND BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 324. SWITZERLAND BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 325. SWITZERLAND BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 326. SWITZERLAND BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 327. SWITZERLAND BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 328. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 329. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 330. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 331. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 332. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 333. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 334. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 335. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 336. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 337. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 338. ASIA-PAC

Companies Mentioned

The companies profiled in this Bioinformatics market report include:
  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • BioDiscovery Group
  • biomodal Limited
  • Dassault Systèmes S.E.
  • DNASTAR, Inc.
  • Eurofins Genomics LLC
  • F. Hoffmann-La Roche Ltd
  • Genevia Technologies Oy
  • Genomics Ltd.
  • HaploX
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc.
  • Labcorp Genetics Inc.
  • Labvantage - Biomax GmbH
  • Novo Nordisk A/S
  • Oxford Nanopore Technologies plc.
  • Pacific Biosciences of California, Inc.
  • Partek Incorporated
  • PerkinElmer, Inc.
  • Qiagen N.V.
  • RIKEN GENESIS CO.,LTD.
  • SOPHiA GENETICS SA
  • Telesis Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Veracyte, Inc.
  • Waters Corporation

Table Information